Waters(US:WAT) Prnewswire·2025-05-06 10:00Core Insights - Waters Corporation reported first quarter 2025 sales of $662 million, a 4% increase from $637 million in the same quarter of 2024, and a 7% increase in constant currency [1][12] - The company achieved diluted earnings per share (EPS) of $2.03 on a GAAP basis and $2.25 on a non-GAAP basis, reflecting a year-over-year growth of 2% in non-GAAP EPS, despite a five percentage point negative impact from foreign exchange [2][12] - The company raised its full-year 2025 guidance for constant currency sales growth to a range of +5.0% to +7.0% and non-GAAP EPS guidance to $12.75 to $13.05, indicating an expected year-over-year growth of approximately +8% to +10% [4][5][12] Financial Performance - First quarter 2025 sales growth was driven by an 11% increase in instrument sales in constant currency, particularly strong in the pharmaceutical and industrial markets [3][12] - The company reported net income of $121.4 million for the first quarter, compared to $102.2 million in the same period last year [23] - Operating income for the first quarter was $151.7 million, up from $133.8 million in the prior year [23] Guidance and Outlook - For the second quarter of 2025, Waters Corporation expects constant currency sales growth in the range of +5.0% to +7.0% and reported sales growth of +4.0% to +6.0% [6] - The projected non-GAAP EPS for the second quarter is expected to be between $2.88 and $2.98, representing a year-over-year growth of approximately +10% to +13% [6][24] - The company’s operational actions and improvements in foreign exchange are expected to mitigate the impact of tariffs and policy changes [3][12]